Bluelinea SA (ALBLU) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.615x

Based on the latest financial reports, Bluelinea SA (ALBLU) has a cash flow conversion efficiency ratio of -0.615x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-434.85K ≈ $-508.39K USD) by net assets (€706.70K ≈ $826.20K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bluelinea SA (ALBLU) market capitalisation for the company's overall valuation and market capitalisation.

Bluelinea SA - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Bluelinea SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bluelinea SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bluelinea SA ranked by their cash flow conversion efficiency. See ALBLU cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Card Factory PLC LSE:CARD	0.063x
Automax Motors Ltd TA:AMX	-1.803x
Azincourt Uranium Inc V:AAZ	-0.089x
Molinos Rio de la Plata SA BA:MOLI5	0.304x
Metalex Ventures Ltd. V:MTX	-0.095x
Burley Minerals Ltd AU:BUR	-0.170x
Kitwave Group PLC LSE:KITW	0.122x
Usha Resources Ltd V:USHA	0.085x

Annual Cash Flow Conversion Efficiency for Bluelinea SA (2009–2024)

The table below shows the annual cash flow conversion efficiency of Bluelinea SA from 2009 to 2024. View latest Bluelinea SA stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€1.41 Million ≈ $1.65 Million	€857.90K ≈ $1.00 Million	0.607x	+352.87%
2023-12-31	€2.68 Million ≈ $3.14 Million	€-644.38K ≈ $-753.35K	-0.240x	-2.49%
2022-12-31	€4.30 Million ≈ $5.03 Million	€-1.01 Million ≈ $-1.18 Million	-0.234x	-176.82%
2021-12-31	€-1.85 Million ≈ $-2.17 Million	€-565.52K ≈ $-661.15K	0.305x	+111.34%
2020-12-31	€886.46K ≈ $1.04 Million	€-2.39 Million ≈ $-2.79 Million	-2.691x	-2997.46%
2019-12-31	€2.27 Million ≈ $2.65 Million	€-196.87K ≈ $-230.16K	-0.087x	+41.82%
2018-12-31	€5.05 Million ≈ $5.91 Million	€-754.86K ≈ $-882.51K	-0.149x	+99.37%
2017-12-31	€6.35K ≈ $7.42K	€-149.58K ≈ $-174.88K	-23.557x	+90.18%
2016-12-31	€9.34K ≈ $10.92K	€-2.24 Million ≈ $-2.62 Million	-239.813x	-167621.39%
2015-12-31	€7.45K ≈ $8.71K	€-1.07K ≈ $-1.25K	-0.143x	+75.05%
2014-12-31	€2.92 Million ≈ $3.41 Million	€-1.67 Million ≈ $-1.96 Million	-0.573x	-30.80%
2013-12-31	€1.96 Million ≈ $2.29 Million	€-856.72K ≈ $-1.00 Million	-0.438x	-61.22%
2012-12-31	€2.22 Million ≈ $2.59 Million	€-602.23K ≈ $-704.07K	-0.272x	-51.44%
2009-12-31	€-367.77K ≈ $-429.97K	€66.00K ≈ $77.16K	-0.179x	--

About Bluelinea SA

PA:ALBLU France Medical Devices

Market Cap

$3.00 Million

€2.57 Million EUR

Market Cap Rank

#29569 Global

#539 in France

Share Price

€0.14

Change (1 day)

-6.67%

52-Week Range

€0.14 - €0.63

All Time High

€6.30